Canaccord Raises C3.ai Price Target as Siebel Becomes CEO
Canaccord Genuity raised its price target on C3.ai to $8 from $7 after Tom Siebel returned as CEO, amid preliminary Q...
Frequent budget adjustments help you respond to income shifts and spending surprises. This intro guides quick, practical tweaks for staying on track.
26,559 articlesCanaccord Genuity raised its price target on C3.ai to $8 from $7 after Tom Siebel returned as CEO, amid preliminary Q...
As bitcoin oscillates, MSTY investors confront a structural risk tied to the ETF’s option strategy. The fund’s income...
Nvidia CEO Jensen Huang’s remark on AI-proof degrees has sparked a broader debate about job security in an era of rap...
OpenAI has filed confidential IPO paperwork with the SEC, signaling a public listing could be on the horizon. The mov...
Global policymakers wrestle with ai sovereignty as the economy and everyday life increasingly rely on frontier AI. Th...
Tesla unveils a chip breakthrough deal that could redefine its path from auto maker to AI silicon player. Markets rea...
Investors are buzzing about a hypothetical $165 billion payout for Elon Musk tied to SpaceX milestones. Traders say t...
Cardano’s Van Rossem hard fork is set to activate tomorrow, amid a surge in whale buying and rising open interest. Tr...
Alphabet reportedly priced a rare 100-year bond to back AI and data-center expansion, a move that stirs debate on lon...
A single day shows $31.6m ethereum leaves exchanges, pushing reserves to multi-year lows and reigniting bets on a pot...
Oil breaks $100 again as Middle East tensions flare, lifting energy stocks and reshaping risk-on bets for 2026. Inves...
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...